Suppr超能文献

卵清蛋白诱导的致敏大鼠膀胱神经源性炎症

Ovalbumin-induced neurogenic inflammation in the bladder of sensitized rats.

作者信息

Ahluwalia A, Giuliani S, Scotland R, Maggi C A

机构信息

Centre for Clinical Pharmacology, The Rayne Institute, University College London.

出版信息

Br J Pharmacol. 1998 May;124(1):190-6. doi: 10.1038/sj.bjp.0701793.

Abstract
  1. We have developed and characterized a model of immediate hypersensitivity/inflammation of the urinary bladder in vivo induced by local application of ovalbumin (OA) in OA- sensitive female rats. Two parameters of the inflammatory response were assessed following OA challenge: plasma protein extravasation (PPE) and changes in smooth muscle reactivity. The former was estimated by measurement of Evans blue extravasation at 0.5, 2, 4, 8 and 24 h time point following in vivo challenge. Changes in reactivity were determined by measurement of isotonic tension responses of urinary bladder strips following OA challenge in vitro. 2. Acute in vivo intravesical OA challenge (10 mg in 0.3 ml saline) in actively sensitized female Wistar rats caused a time-dependent PPE in the urinary bladder which was biphasic with peak responses at 2-4 and 24 h. 3. The PPE response to acute OA challenge, above base-line, at 2 h was abolished by systemic capsaicin pretreatment (50 mg kg(-1), s.c., 4 days before use) (P < 0.05) whilst the response at 24 h was unaffected. The 2 h time point was then used for further studies. 4. Degranulation of mast cells, achieved by pretreatment with compound 48/80 (5 mg kg(-1), s.c. for 3 consecutive days), completely abolished the PPE response to OA challenge at the 2 h time point. 5. The tachykinin NK1 receptor antagonist, SR 140333 (0.1 micromol kg(-1), i.v.), abolished the 2 h PPE response whilst the tachykinin NK2 receptor antagonist MEN 11420 (0.1 micromol kg(-1), i.v.) appeared to reduce the response by approximately 50% but this did not reach significance. The bradykinin B2 receptor antagonist, Hoe 140 (0.1 micromol kg(-1), i.v.), similarly to SR 140333, blocked the 2 h PPE response to OA, whereas the selective B1 receptor antagonist B 9858 (0.1 micromol kg(-1), i.v.) had no significant effect. Inhibition of cyclo-oxygenase (COX) achieved by pretreatment with the COX inhibitor dexketoprofen (5.3 micromol kg(-1), i.v.) also blocked the PPE response, whilst the leukotriene receptor antagonist ONO 1078 (1 micromol kg(-1), i.v.) significantly reduced PPE by about 80%. 6. In the rat isolated urinary bladder OA (1 mg ml(-1)) challenge produced a biphasic response with a rapidly achieved maximal contraction followed by a sustained contraction for approximately 25 min. In vitro capsaicin pretreatment (10 microM for 15 min) significantly attenuated the duration of the sustained contraction whilst having no effect on the maximum contractile response achieved. In vivo pretreatment of animals with compound 48/80 significantly attenuated (42%) the maximum contractile response. Combination of both treatments almost completely abolished the response. In vitro treatment with Hoe 140 (1 microM) had no significant effect on the response to OA and neither did ONO 1078 (1 microM). 7. These results show that both the early inflammatory response and alterations in smooth muscle reactivity to OA challenge in actively sensitized animals are dependent on mast cell degranulation and the activation of sensory C-fibres. Furthermore this model of allergic cystitis may be useful for investigating both the processes involved and potential novel therapies in the treatment of interstitial cystitis.
摘要
  1. 我们已经建立并鉴定了一种体内速发型超敏反应/膀胱炎症模型,该模型通过在对卵清蛋白(OA)敏感的雌性大鼠局部应用卵清蛋白(OA)诱导产生。在OA激发后评估炎症反应的两个参数:血浆蛋白外渗(PPE)和平滑肌反应性变化。前者通过在体内激发后0.5、2、4、8和24小时时间点测量伊文思蓝外渗来估计。反应性变化通过在体外OA激发后测量膀胱条带的等张张力反应来确定。2. 在主动致敏的雌性Wistar大鼠中进行急性体内膀胱内OA激发(0.3 ml盐水中含10 mg),导致膀胱中出现时间依赖性的PPE,呈双相性,在2 - 4小时和24小时出现峰值反应。3. 全身性辣椒素预处理(50 mg kg⁻¹,皮下注射,使用前4天)可消除在2小时时高于基线的急性OA激发的PPE反应(P < 0.05),而24小时时的反应不受影响。然后将2小时时间点用于进一步研究。4. 通过用化合物48/80预处理(5 mg kg⁻¹,皮下注射,连续3天)实现肥大细胞脱颗粒,在2小时时间点完全消除了对OA激发的PPE反应。5. 速激肽NK1受体拮抗剂SR 140333(0.1 μmol kg⁻¹,静脉注射)消除了2小时的PPE反应,而速激肽NK2受体拮抗剂MEN 11420(0.1 μmol kg⁻¹,静脉注射)似乎使反应降低了约50%,但未达到显著水平。缓激肽B2受体拮抗剂Hoe 140(0.1 μmol kg⁻¹,静脉注射)与SR 140333类似,阻断了对OA的2小时PPE反应,而选择性B1受体拮抗剂B 9858(0.1 μmol kg⁻¹,静脉注射)没有显著影响。通过用COX抑制剂右酮洛芬预处理(5.3 μmol kg⁻¹,静脉注射)抑制环氧化酶(COX)也阻断了PPE反应,而白三烯受体拮抗剂ONO 1078(1 μmol kg⁻¹,静脉注射)使PPE显著降低了约80%。6. 在大鼠离体膀胱中,OA(1 mg ml⁻¹)激发产生双相反应,迅速达到最大收缩,随后持续收缩约25分钟。体外辣椒素预处理(10 μM,15分钟)显著缩短了持续收缩的持续时间,而对达到的最大收缩反应没有影响。用化合物48/80对动物进行体内预处理显著减弱了(42%)最大收缩反应。两种处理联合几乎完全消除了反应。用Hoe 140(1 μM)进行体外处理对OA反应没有显著影响,ONO 1078(1 μM)也没有影响。7. 这些结果表明,在主动致敏动物中,早期炎症反应和平滑肌对OA激发的反应性改变均依赖于肥大细胞脱颗粒和感觉C纤维的激活。此外,这种过敏性膀胱炎模型可能有助于研究参与的过程以及间质性膀胱炎治疗中的潜在新疗法。

相似文献

6
MN-001, a novel oral anti-inflammatory agent, suppresses bladder hyperactivity in a rat model.
BJU Int. 2006 Aug;98(2):430-4. doi: 10.1111/j.1464-410X.2006.06274.x.

引用本文的文献

3
Role of neurogenic inflammation in local communication in the visceral mucosa.神经原性炎症在肠黏膜局部通讯中的作用。
Semin Immunopathol. 2018 May;40(3):261-279. doi: 10.1007/s00281-018-0674-0. Epub 2018 Mar 26.
5
Purinergic signalling in the urinary tract in health and disease.健康与疾病状态下尿路中的嘌呤能信号传导。
Purinergic Signal. 2014 Mar;10(1):103-55. doi: 10.1007/s11302-013-9395-y. Epub 2013 Nov 22.
9
Neuropeptides in lower urinary tract function.下尿路功能中的神经肽
Handb Exp Pharmacol. 2011(202):395-423. doi: 10.1007/978-3-642-16499-6_19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验